Marca Nominativa depositada no INPI em 02/12/2021 por Enterobiotix Limited, processo nº 501655920, nas classes 01, 05, 09, 10, 42, 44. Registro em vigor até 02/12/2031.
| Número do processo | 501655920 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 02/12/2021 |
| Data da concessão | 06/06/2023 |
| Vigência até | 02/12/2031 |
| Titular | Enterobiotix Limited |
| CNPJ/CPF do titular | — |
| UF · País | — · GB |
Chemicals, reagents and substances for medical research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; diagnostic preparations and reagents for scientific or research use; enzymes for scientific purposes; raw proteins; proteins for use in industry and in science; test kits for scientific or research use, comprised of buffer solutions, assays and reagents.;
Pharmaceutical and medical preparations; pharmaceutical and medical preparations in the field of microbiome modulating therapeutics; pharmaceutical or medical preparations and substances; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of gastrointestinal disorders and diseases; drugs for medical purposes; biotechnological preparations for medical use, biological compounds for use in targeted pharmaceutical therapies; proteins with diagnostic and therapeutic uses for medical purposes; chemical and enzyme preparations for medical purposes; reagents and substances for use in testing for medical purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; intestinal microbiome pharmaceutical preparations; clinical medical reagents; diagnostic and testing preparations for clinical, medical and medical laboratory use; diagnostic reagents and assay components for clinical, medical and medical laboratory use; enzymes for medical purposes; yeast for intracellular production of recombinant proteins being biochemical preparations for medical purposes; yeast for pharmaceutical purposes; dietary supplements; food supplements; topical gels for medical and therapeutic use; intestinal microbiome medicinal preparations; pharmaceuticals or therapeutic preparations in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; diagnostic preparations for use in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; medical preparations for use in connection with intestinal microbiota transfer; chemical preparations and products, for use in medicine; diagnostic biomarkers for in vitro or in vivo testing for medical use.;
Computer software; software applications; mobile applications; cloud computing software; software algorithms; biometric software; databases; directories [electric or electronic]; artificial intelligence software for healthcare; health monitoring software; computer software for use in the fields of physiology, biology, genetics, genomics, metagenomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics and/or prebiotics; computer software for use in the fields of biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences and/or bacteria; computer software for scientific analysis of genetic sequences; interactive computer software; media streaming software; machine learning software for healthcare; machine learning software for analysis; downloadable computer software for remote monitoring and analysis; computer application software for streaming audio-visual media content via the internet; computer programs; encoded programs; measuring, detecting, monitoring and electronic controlling devices; wearable devices for taking biological measurements; instruments for analysing physical data; publications in electronic form; downloadable publications; electronic communications apparatus; scientific apparatus and instruments; teaching apparatus and instruments; apparatus and instruments for the recording, transmission or reproduction of data, sound or images; devices for analysing protein sequence used as laboratory apparatus; computers and computer hardware; encoded cards; smart cards; smart card readers; electronically encoded identity bracelets; parts and fittings for all the aforesaid goods.;
Medical devices; medical apparatus and instruments; medical analysis instruments; medical apparatus for introducing pharmaceutical preparations into the human body; medical instruments for use in connection with intestinal microbiota transfer; testing instruments for medical diagnostic purposes in relation to genetics, the human immune system and the human gut microbiome; medical diagnostic and testing apparatus in the field of microbiology; diagnostic and medical testing apparatus in the field of microbiome modulating therapeutics; medical diagnostic and testing apparatus in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; gloves for medical examinations; bags adapted for medical use; parts and fittings for all the aforesaid goods.;
Research and development services in the fields of medicine and health; research and development in the pharmaceutical and biotechnology fields; biological, scientific, clinical and medical research and development; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of compounds for use in targeted pharmaceutical therapies; medical and pharmacological research services; research relating to molecular sciences and biotechnology; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; scientific and medical research services in the field of microbiome modulating therapeutics; research and development of pharmaceutical preparations for the treatment of gastrointestinal disorders and diseases; research and development of biological drug delivery platforms; biochemical research and analysis; bacteriological research and analysis; scientific analysis in the field of intestinal microbiology; analysis of human excreta for medical research; microbiological testing; biological analysis; research, development, analysis and evaluation services in connection with biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences, bacteria, physiology, biology, genetics, genomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics, prebiotics and nutraceutical supplements; research and development services in connection with health care, wellness, physical well-being, mental well-being, exercise, weight planning, weight management, diet, nutrition and/or sleep; research, development, analysis and evaluation services in connection with microbiology, genetics, the human immune system and the human gut microbiome; research and development in connection with gastrointestinal health; DNA screening for scientific research purposes; testing of pharmaceuticals; testing, authentication and quality control; biotechnology and chemical testing; development of biochemical reagents; laboratory services; clinical research; clinical trials; conducting early evaluations in the field of new pharmaceuticals; research and development for use in clinical trials; providing information about the results of clinical trials for pharmaceutical products; technical measuring and testing services; structural and functional analysis of genomes; services for assessing the efficiency of medical and veterinary drugs; veterinary research and development services; product design and development; design services relating to the biotechnology industry; analysis of product development; pharmaceutical product evaluation; preparation of scientific reports in the field of biotechnology and/or gut health; scientific research and analysis; scientific research project management; scientific risk assessment; industrial analysis and research; analysis of product design; quality assessment; software design, development, programming and implementation; software engineering; development and design of mobile applications; computer programming; development of computer platforms; design, development and testing of computing methods, algorithms and software; software as a service [SAAS]; platform as a service [PaaS]; platform as a service featuring a computer software platform that enables access to technical studies and scientific and medical information; application service provider [ASP]; computer software maintenance; software and algorithm research; information technology services for the pharmaceutical and healthcare industries; writing of computer programs for biotechnological applications; development of virtual reality software; design and development of software for use in the fields of biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences and/or bacteria; database design; maintenance of database software; design and development of computer hardware; online data storage; cross-platform conversion of digital content into other forms of digital content; technical data analysis; data encryption services; updating of software; rental of software; data coding services being computer programming; process monitoring for quality assurance; hosting websites on the internet in the field of healthcare and wellness; DNA sequencing and sequencing of microbiomes in humans for research purposes; consultancy, information and advisory services relating to all of the aforesaid services.;
Medical and healthcare services; medical examinations; medical analysis services; health assessment surveys; health risk assessment surveys; medical health assessment services; medical analysis services relating to the treatment of persons; medical care services relating to patient treatment; analysis of human tissues for medical treatment; genetic testing for medical purposes; DNA screening for medical purposes; medical and health services relating to DNA, genetics and genetic testing; medical services relating to DNA sequencing and sequencing of microbiomes in humans; diagnostic testing and analysis services for medical purposes; analysis of human serum for medical treatment; analysis of human excreta for medical treatment; human serum donation services; donation of bodily fluids and human waste; donation of human excreta; behavioural analysis for medical purposes; psychological assessment services; providing online medical record services; preparation of reports relating to medical matters; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing health information via a website; medical services connected with intestinal microbiota transfer; consultancy, information and advisory services relating to all of the aforesaid services.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501655920 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas6 despacho(s) publicado(s) na Revista da Propriedade Industrial.